Therapeutic genome engineering relies on the development of reliable, robust and versatile tools. Here the authors develop Cas9-Cas9 chimeras with high target site activity that generate predictable deletions.
- Mehmet Fatih Bolukbasi
- Pengpeng Liu
- Scot A. Wolfe